1. Home
  2. AMPH

AMPH

Amphastar Pharmaceuticals Inc.

Logo Amphastar Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 3:30pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Founded: 1996 Country:
United States
United States
Employees: N/A City: RANCHO CUCAMONGA
Market Cap: 2.0B IPO Year: 2014
Target Price: $59.25 AVG Volume (30 days): 438.8K
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.60 EPS Growth: 49.43
52 Week Low/High: $35.62 - $67.66 Next Earning Date: 05-07-2024
Revenue: $644,395,000 Revenue Growth: 29.14%
Revenue Growth (this year): 17.04% Revenue Growth (next year): 9.97%

Share on Social Networks:

Stock Insider Trading Activity of Amphastar Pharmaceuticals Inc. (AMPH)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Petersen Floyd F. AMPH Director Apr 1 '24 Sell $43.43 500 $21,714.15 79,333 SEC Form 4
Petersen Floyd F. AMPH Director Feb 1 '24 Sell $53.07 474 $25,153.76 80,359 SEC Form 4
Petersen Floyd F. AMPH Director Feb 1 '24 Sell $53.64 26 $1,394.64 80,333 SEC Form 4
Petersen Floyd F. AMPH Director Jan 2 '24 Sell $60.56 147 $8,902.08 81,186 SEC Form 4
Petersen Floyd F. AMPH Director Jan 2 '24 Sell $61.70 353 $21,780.84 80,833 SEC Form 4
Deflin Gayle AMPH Director Nov 14 '23 Sell $55.45 4,163 $230,838.35 2,716 SEC Form 4
PRINS RICHARD K AMPH Director Nov 13 '23 Sell $52.50 5,000 $262,500.00 35,895 SEC Form 4